A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma
Clinical trial NCT02451943 · COMPLETED
Trial details
- NCT number
- NCT02451943
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-14
- Primary completion
- 2018-12-05
- Enrollment
- 509
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.